HCPLive 5 Stories in Under 5: Week of 08/10
- Author
- HCPLive.com
- Published
- Mon 18 Aug 2025
- Episode Link
- https://audioboom.com/posts/8764588
Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impacting clinicians and healthcare providers like you!
Interested in a more traditional, text rundown? Check out the HCPFive!
Top 5 Healthcare Headlines for August 10-16, 2025:
FDA Approves 2 Generic Iron Sucrose Injections for Iron Deficiency Anemia in CKD
The FDA approved 2 generic versions of iron sucrose injection for treating iron deficiency anemia in patients with CKD, expanding access to therapy.
FDA Approves PharmaTher’s Ketamine for Surgical Pain Management
The FDA approved PharmaTher’s ketamine formulation for surgical pain management following resolution of earlier application deficiencies.
HFSA and ASPC Release Statement on Shifting to Prevention in Heart Failure
The HFSA and ASPC issued a joint statement urging clinicians to prioritize prevention and early risk management in heart failure care.
Zopapogene Imadenovec First Immunotherapy Approved for Recurrent Respiratory Papillomatosis
The FDA approved zopapogene imadenovec as the first immunotherapy for recurrent respiratory papillomatosis, offering a new treatment option.
AHA & ACC Release New Guidelines for High Blood Pressure to Reduce CVD Risk
The AHA and ACC released updated hypertension guidelines recommending earlier intervention to lower cardiovascular disease risk.
Interested in a more traditional, text rundown? Check out the HCPFive!
Top 5 Healthcare Headlines for August 10-16, 2025:
FDA Approves 2 Generic Iron Sucrose Injections for Iron Deficiency Anemia in CKD
The FDA approved 2 generic versions of iron sucrose injection for treating iron deficiency anemia in patients with CKD, expanding access to therapy.
FDA Approves PharmaTher’s Ketamine for Surgical Pain Management
The FDA approved PharmaTher’s ketamine formulation for surgical pain management following resolution of earlier application deficiencies.
HFSA and ASPC Release Statement on Shifting to Prevention in Heart Failure
The HFSA and ASPC issued a joint statement urging clinicians to prioritize prevention and early risk management in heart failure care.
Zopapogene Imadenovec First Immunotherapy Approved for Recurrent Respiratory Papillomatosis
The FDA approved zopapogene imadenovec as the first immunotherapy for recurrent respiratory papillomatosis, offering a new treatment option.
AHA & ACC Release New Guidelines for High Blood Pressure to Reduce CVD Risk
The AHA and ACC released updated hypertension guidelines recommending earlier intervention to lower cardiovascular disease risk.
